AU2001246338A1 - Taxol liposome composition for treatment of cancer and preparation thereof - Google Patents

Taxol liposome composition for treatment of cancer and preparation thereof

Info

Publication number
AU2001246338A1
AU2001246338A1 AU2001246338A AU4633801A AU2001246338A1 AU 2001246338 A1 AU2001246338 A1 AU 2001246338A1 AU 2001246338 A AU2001246338 A AU 2001246338A AU 4633801 A AU4633801 A AU 4633801A AU 2001246338 A1 AU2001246338 A1 AU 2001246338A1
Authority
AU
Australia
Prior art keywords
parts
cancer
treatment
liposome composition
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246338A
Other languages
English (en)
Inventor
Guang Cheng
Peiyuan Cheng
Guoying Weng
Wei Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zhenzhong Bioengineering Co Ltd
Original Assignee
NANJING ZHENZHONG BIOENGINEERI
Nanjing Zhenzhong Bioengineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING ZHENZHONG BIOENGINEERI, Nanjing Zhenzhong Bioengineering Co Ltd filed Critical NANJING ZHENZHONG BIOENGINEERI
Publication of AU2001246338A1 publication Critical patent/AU2001246338A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001246338A 2000-10-19 2001-02-28 Taxol liposome composition for treatment of cancer and preparation thereof Abandoned AU2001246338A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00119039 2000-10-19
CN00119039A CN1116875C (zh) 2000-10-19 2000-10-19 紫杉醇脂质组合物及其制备方法
PCT/CN2001/000309 WO2002032399A1 (fr) 2000-10-19 2001-02-28 Composition pharmaceutique pour le traitement du cancer combinant le taxol et un liposome ainsi que son procede de preparation

Publications (1)

Publication Number Publication Date
AU2001246338A1 true AU2001246338A1 (en) 2002-04-29

Family

ID=4587434

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246338A Abandoned AU2001246338A1 (en) 2000-10-19 2001-02-28 Taxol liposome composition for treatment of cancer and preparation thereof

Country Status (9)

Country Link
EP (1) EP1332755B1 (de)
JP (1) JP4890732B2 (de)
CN (1) CN1116875C (de)
AT (1) ATE482688T1 (de)
AU (1) AU2001246338A1 (de)
DE (1) DE60143168D1 (de)
ES (1) ES2353488T3 (de)
RU (1) RU2264807C2 (de)
WO (1) WO2002032399A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
AR054215A1 (es) 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
CN100364525C (zh) * 2006-04-12 2008-01-30 中国药科大学 含壳聚糖衍生物的多西他塞脂质体、冻干制剂及制备方法
CN100386069C (zh) * 2006-06-26 2008-05-07 裴泽军 亮菌甲素脂质体制剂及其制备方法
CN101015525B (zh) * 2007-02-15 2012-02-22 沈阳药科大学 紫杉醇脂质体及其制备方法
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
AR063111A1 (es) 2007-10-03 2008-12-30 Eriochem Sa Una formulacion farmaceutica de taxano
JP5622719B2 (ja) * 2009-03-30 2014-11-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 リポソーム組成物の製造方法
US20120058178A1 (en) 2009-03-30 2012-03-08 Eisai R&D Management Co., Ltd. Liposome Composition
CN102048725B (zh) * 2009-10-29 2014-07-16 中国医学科学院药物研究所 紫杉醇胆固醇复合物
AU2011292044A1 (en) 2010-08-18 2013-04-04 Del Mar Pharmaceuticals Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
WO2012129957A1 (zh) * 2011-03-28 2012-10-04 Zhao Wenzhi 几种药物配方
EP2758043A4 (de) 2011-08-17 2016-02-24 Dennis M Brown Zusammensetzungen und verfahren zur erhöhung des therapeutischen nutzens von suboptimal verabreichten chemischen verbindungen einschliesslich substituierter hexitole wie dibromodulcitol
CN115813902A (zh) 2012-01-20 2023-03-21 德玛公司 经取代的己糖醇类用于治疗恶性肿瘤的用途
WO2013142817A2 (en) 2012-03-23 2013-09-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
WO2013169600A1 (en) 2012-05-09 2013-11-14 Delmar Pharmaceuticals Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
MX367055B (es) 2012-06-26 2019-08-02 Del Mar Pharmaceuticals El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa.
EP3581186A1 (de) 2012-11-29 2019-12-18 Insmed Incorporated Stabilisierte vancomycin-formulierungen
RU2516893C1 (ru) * 2012-12-14 2014-05-20 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий" Липосомальная композиция и способ ее получения
KR20160104612A (ko) 2013-07-26 2016-09-05 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조성물
SG11201601311VA (en) * 2013-09-13 2016-03-30 Arbor Therapeutics Llc Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
CN103705475A (zh) * 2013-12-27 2014-04-09 桂林南药股份有限公司 一种青蒿琥酯冻干粉针剂组合物及其制备方法
JP2015193580A (ja) * 2014-03-31 2015-11-05 テルモ株式会社 アムホテリシンｂリポソームの製造方法
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
CN106924195B (zh) * 2015-12-31 2020-11-13 南京绿叶制药有限公司 一种注射用紫杉醇脂质体组合物的冻干工艺
AU2017350499B2 (en) * 2016-10-28 2023-08-10 Les Laboratoires Servier Liposomal formulation for use in the treatment of cancer
LU101155B1 (en) * 2017-07-19 2019-04-25 Tesorx Pharma Llc Liposomal Paclitaxel Formulation for Treating Bladder Cancer
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN111329838B (zh) * 2020-05-09 2020-11-20 南京绿叶制药有限公司 一种紫杉醇脂质体药物组合物及其制备方法
CN112754996B (zh) * 2021-03-16 2023-03-31 江西省科学院生物资源研究所 一种鱼精蛋白短肽修饰的紫杉醇脂质体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576017A (en) * 1988-05-30 1996-11-19 Depotech Corporation Heterovesicular liposomes
ES2148223T3 (es) * 1992-03-23 2000-10-16 Univ Georgetown Taxol encapsulado en liposomas y metodo para su uso.
WO1994026254A1 (en) * 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation of taxol into liposomes and gels
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
CN1148957A (zh) * 1996-09-02 1997-05-07 张海茹 紫杉醇水溶性粉针剂及其制备方法
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes

Also Published As

Publication number Publication date
DE60143168D1 (de) 2010-11-11
RU2264807C2 (ru) 2005-11-27
CN1116875C (zh) 2003-08-06
CN1291474A (zh) 2001-04-18
ES2353488T3 (es) 2011-03-02
EP1332755A4 (de) 2005-03-09
EP1332755B1 (de) 2010-09-29
EP1332755A1 (de) 2003-08-06
JP2004516247A (ja) 2004-06-03
JP4890732B2 (ja) 2012-03-07
ATE482688T1 (de) 2010-10-15
WO2002032399A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001246338A1 (en) Taxol liposome composition for treatment of cancer and preparation thereof
WO2002094984A3 (en) Process for preparing purified shilajit composition from native shilajit
LU92060I9 (de)
AU3455699A (en) Water soluble paclitaxel derivatives
CA2320182A1 (en) Compositions containing organic compounds
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
WO2002043659A3 (en) Composition containing statins and calcium for improved cardiovascular health
EP1496076A4 (de) Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
CA2129288A1 (en) Phosphonooxymethyl Esters of Taxane Derivatives
IL159773A0 (en) Taxol enhancer compounds
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
WO2002043765A3 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
CA2163706A1 (en) Amino Acid Derivatives of Paclitaxel
AUPQ266199A0 (en) Compositions and therapeutic methods involving isoflavones and analogues thereof
WO2006020719A3 (en) Aminoacid conjugates of beta - lapachone for tumor targeting
WO2003022208A3 (en) Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
DE69703228T2 (de) Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon
IL158155A (en) Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
WO2003090744A8 (en) Antibacterial compositions comprising metal phthalocyanine analogues
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
WO2005062985A8 (en) Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications